CCL2 and Alzheimer disease: First, the sample size is relatively small, and the aMCI and AD subgroups were pooled together as one group, which may have negatively impacted statistical power, such as the power of MCP-1 in ADEs to discriminate SCD from NC or the relevance of MCP-1 in ADEs to cognitive function.